文献库，生知库 | 链接生命科学的每一步

日期影响因子

ROR1 targeting with the antibody-drug conjugate VLS-101 is effective in Richter syndrome patient-derived xenograft mouse models

使用抗体药物偶联物VLS-101靶向ROR1在里氏综合征患者来源的异种移植小鼠模型中有效。

影响因子:23.1

doi:10.1182/blood.2020008404

Vaisitti, Tiziana; Arruga, Francesca; Vitale, Nicoletta; Lee, Thanh-Trang; Ko, Mira; Chadburn, Amy; Braggio, Esteban; Di Napoli, Arianna; Iannello, Andrea; Allan, John N; Miller, Langdon L; Lannutti, Brian J; Furman, Richard R; Jessen, Katti A; Deaglio, Silvia

发表日期：2021

文献求助收藏

The phosphoinositide 3'-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia.

磷脂酰肌醇 3'-激酶δ抑制剂CAL-101可抑制慢性淋巴细胞白血病中的B细胞受体信号传导和趋化因子网络

影响因子:23.1

doi:10.1182/blood-2011-05-352492

Hoellenriegel Julia, Meadows Sarah A, Sivina Mariela, Wierda William G, Kantarjian Hagop, Keating Michael J, Giese Neill, O'Brien Susan, Yu Albert, Miller Langdon L, Lannutti Brian J, Burger Jan A

细胞生物学

发表日期：2011

文献求助收藏

Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience

伊立替康（CPT-11）治疗高危恶性脑肿瘤患儿的II期研究：杜克大学的经验

期刊:Neuro-Oncology

影响因子:13.4

doi:10.1093/neuonc/4.2.109

Turner, Christopher D; Gururangan, Sridharan; Eastwood, James; Bottom, Krystal; Watral, Melody; Beason, Rodney; McLendon, Roger E; Friedman, Allan H; Tourt-Uhlig, Sandra; Miller, Langdon L; Friedman, Henry S

发表日期：2002

文献求助收藏